These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7620086)

  • 1. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis.
    Couser WG; Johnson RJ; Young BA; Yeh CG; Toth CA; Rudolph AR
    J Am Soc Nephrol; 1995 May; 5(11):1888-94. PubMed ID: 7620086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase induction in Thy 1 glomerulonephritis is complement and reactive oxygen species dependent.
    Mosley K; Waddington SN; Ebrahim H; Cook T; Cattell V
    Exp Nephrol; 1999; 7(1):26-34. PubMed ID: 9892811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
    Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG
    Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of terminal complement components in experimental immune glomerular injury.
    Adler S; Baker PJ; Pritzl P; Couser WG
    Kidney Int; 1984 Dec; 26(6):830-7. PubMed ID: 6241952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    Mulligan MS; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.
    Weisman HF; Bartow T; Leppo MK; Marsh HC; Carson GR; Concino MF; Boyle MP; Roux KH; Weisfeldt ML; Fearon DT
    Science; 1990 Jul; 249(4965):146-51. PubMed ID: 2371562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the SCR1-3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats.
    Yang S; Wang X; Zhang X; Lu Y; Wang Z
    Neurol Res; 2013 Nov; 35(9):976-83. PubMed ID: 23815859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
    Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A
    Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble human complement receptor type 1 inhibits complement-mediated host defense.
    Swift AJ; Collins TS; Bugelski P; Winkelstein JA
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):585-9. PubMed ID: 8556505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney.
    Saunders JR; Aminian A; McRae JL; O'Farrell KA; Adam WR; Murphy BF
    Kidney Int; 1994 Mar; 45(3):817-27. PubMed ID: 8196284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.
    Schiller B; He C; Salant DJ; Lim A; Alexander JJ; Quigg RJ
    J Exp Med; 1998 Oct; 188(7):1353-8. PubMed ID: 9763614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats.
    Yeh CG; Marsh HC; Carson GR; Berman L; Concino MF; Scesney SM; Kuestner RE; Skibbens R; Donahue KA; Ip SH
    J Immunol; 1991 Jan; 146(1):250-6. PubMed ID: 1824590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.